These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38607328)

  • 1. Long-term prognostic value of the H
    Ishizu K; Shirai S; Isotani A; Hayashi M; Tabata H; Ohno N; Kakumoto S; Ando K; Yashima F; Tada N; Yamawaki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38607328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the H
    Ludwig S; Pellegrini C; Gossling A; Rheude T; Voigtländer L; Bhadra OD; Linder M; Kalbacher D; Koell B; Waldschmidt L; Schirmer J; Seiffert M; Reichenspurner H; Blankenberg S; Westermann D; Conradi L; Joner M; Schofer N
    ESC Heart Fail; 2021 Feb; 8(1):461-470. PubMed ID: 33215870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation (From the OCEAN-TAVI Registry).
    Ishizu K; Shirai S; Isotani A; Hayashi M; Kawaguchi T; Taniguchi T; Ando K; Yashima F; Tada N; Yamawaki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Am J Cardiol; 2021 Jun; 149():86-94. PubMed ID: 33753041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2FPEF Score as a Prognostic Value in HFpEF Patients.
    Sueta D; Yamamoto E; Nishihara T; Tokitsu T; Fujisue K; Oike F; Takae M; Usuku H; Takashio S; Arima Y; Suzuki S; Nakamura T; Ito M; Kanazawa H; Sakamoto K; Kaikita K; Tsujita K
    Am J Hypertens; 2019 Oct; 32(11):1082-1090. PubMed ID: 31271191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFA-PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation.
    Seoudy H; von Eberstein M; Frank J; Thomann M; Puehler T; Lutter G; Lutz M; Bramlage P; Frey N; Saad M; Frank D
    ESC Heart Fail; 2022 Apr; 9(2):1071-1079. PubMed ID: 35092186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of the Get-with-the-Guidelines Heart-Failure Risk Score (GWTG-HF) after Transcatheter Aortic Valve Replacement in Patients with Low-Flow-Low-Gradient Aortic Valve Stenosis.
    Eckel C; Blumenstein J; Husser O; Sötemann D; Grothusen C; Schlüter J; Becher M; Nef H; Elsässer A; Nickenig G; Möllmann H; Tiyerili V
    Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Modified H2FPEF Score in Patients Receiving Trans-Catheter Aortic Valve Replacement.
    Akao K; Imamura T; Tanaka S; Onoda H; Ushijima R; Sobajima M; Fukuda N; Ueno H; Kinugawa K
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of HFA-PEFF Score in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Alotaibi S; Elbasha K; Landt M; Kaur J; Kurniadi A; Abdel-Wahab M; Toelg R; Richardt G; Allali A
    Cureus; 2022 Jul; 14(7):e27152. PubMed ID: 36017287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of In-Hospital Mortality after Transcatheter Aortic Valve Implantation.
    Krittanawong C; Kumar A; Wang Z; Johnson KW; Rastogi U; Narasimhan B; Kaplin S; Virk HUH; Baber U; Tang W; Lansky AJ; Stone GW
    Am J Cardiol; 2020 Jan; 125(2):251-257. PubMed ID: 31759517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less.
    Adamo M; Fiorina C; Petronio AS; Giannini C; Tamburino C; Barbanti M; Bedogni F; Testa L; Colombo A; Latib A; Bruschi G; Reimers B; Poli A; Nazzaro MS; Curello S; Ettori F
    Am J Cardiol; 2018 Nov; 122(10):1718-1726. PubMed ID: 30227961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Brízido C; Madeira M; Brito J; Madeira S; Campante Teles R; Raposo L; Mesquita Gabriel H; Nolasco T; de Araújo Gonçalves P; Sousa-Uva M; Abecasis M; de Sousa Almeida M; Neves JP; Mendes M
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):E1033-E1043. PubMed ID: 34506074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation.
    Miyawaki N; Ishizu K; Shirai S; Miyahara K; Yamamoto K; Suenaga T; Otani A; Nakano K; Fukushima T; Ko E; Tsuru Y; Nakamura M; Morofuji T; Morinaga T; Hayashi M; Isotani A; Ohno N; Kakumoto S; Ando K
    Am Heart J; 2024 Jun; 275():141-150. PubMed ID: 38876408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the CAPRI risk score to predict heart failure hospitalization post-TAVI: The CAPRI-HF study.
    Harbaoui B; Durand E; Dupré M; Rabilloud M; Souteyrand G; Courand PY; Boussel L; Lefevre T; Eltchaninoff H; Lantelme P
    Int J Cardiol; 2019 Dec; 296():98-102. PubMed ID: 31455517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome comparison of different therapy procedures in surgical high-risk elderly patients with severe aortic stenosis].
    Ye YQ; Wang YT; Li Z; Wang MY; Xu HY; Zhang WJ; Liu QR; Niu GN; Wu YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):13-18. PubMed ID: 28100340
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance of the H
    Tada A; Nagai T; Omote K; Iwano H; Tsujinaga S; Kamiya K; Konishi T; Sato T; Komoriyama H; Kobayashi Y; Takenaka S; Mizuguchi Y; Sato T; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Int J Cardiol; 2021 Nov; 342():43-48. PubMed ID: 34364907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Low-Flow Severe Aortic Stenosis in Small-Body Patients Undergoing TAVR: The OCEAN-TAVI Registry.
    Kataoka A; Watanabe Y; Kozuma K; Nara Y; Nagura F; Kawashima H; Hioki H; Nakashima M; Yamamoto M; Takagi K; Araki M; Tada N; Shirai S; Yamanaka F; Hayashida K;
    JACC Cardiovasc Imaging; 2018 May; 11(5):659-669. PubMed ID: 28528156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation.
    Hoffmann J; Mas-Peiro S; Berkowitsch A; Boeckling F; Rasper T; Pieszko K; De Rosa R; Hiczkiewicz J; Burchardt P; Fichtlscherer S; Zeiher AM; Dimmeler S; Nicotera MV
    ESC Heart Fail; 2020 Oct; 7(5):2597-2610. PubMed ID: 32639677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
    Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
    Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
    BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial.
    ; Toff WD; Hildick-Smith D; Kovac J; Mullen MJ; Wendler O; Mansouri A; Rombach I; Abrams KR; Conroy SP; Flather MD; Gray AM; MacCarthy P; Monaghan MJ; Prendergast B; Ray S; Young CP; Crossman DC; Cleland JGF; de Belder MA; Ludman PF; Jones S; Densem CG; Tsui S; Kuduvalli M; Mills JD; Banning AP; Sayeed R; Hasan R; Fraser DGW; Trivedi U; Davies SW; Duncan A; Curzen N; Ohri SK; Malkin CJ; Kaul P; Muir DF; Owens WA; Uren NG; Pessotto R; Kennon S; Awad WI; Khogali SS; Matuszewski M; Edwards RJ; Ramesh BC; Dalby M; Raja SG; Mariscalco G; Lloyd C; Cox ID; Redwood SR; Gunning MG; Ridley PD
    JAMA; 2022 May; 327(19):1875-1887. PubMed ID: 35579641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.